Cover Image
Read Now

PET diagnostic imaging with prostate-specific membrane antigen for prostate cancer a review of clinical utility, cost-effectiveness, diagnostic accuracy, and guidelines

This report aims to retrieve and review the cost-effectiveness, diagnostic accuracy, and evidence-based guidelines regarding PSMA PET imaging for patients with suspected or confirmed metastatic or BCR of prostate cancer

Bibliographic Details
Main Authors: Edge, Rob, Picheca, Lory (Author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa Canadian Agency for Drugs and Technologies in Health November 17, 2020, 2020
Edition:Version:1.0
Series:CADTH rapid response report: summary with critical appraisal
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 01262nam a2200241 u 4500
001 EB002010812
003 EBX01000000000000001173711
005 00000000000000.0
007 tu|||||||||||||||||||||
008 220201 r ||| eng
100 1 |a Edge, Rob 
245 0 0 |a PET diagnostic imaging with prostate-specific membrane antigen for prostate cancer  |h Elektronische Ressource  |b a review of clinical utility, cost-effectiveness, diagnostic accuracy, and guidelines  |c Rob Edge, Lory Picheca 
250 |a Version:1.0 
260 |a Ottawa  |b Canadian Agency for Drugs and Technologies in Health  |c November 17, 2020, 2020 
300 |a 1 PDF file (37 pages)  |b illustration 
700 1 |a Picheca, Lory  |e [author] 
710 2 |a Canadian Agency for Drugs and Technologies in Health 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a CADTH rapid response report: summary with critical appraisal 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK567203  |3 Volltext 
082 0 |a 610 
520 |a This report aims to retrieve and review the cost-effectiveness, diagnostic accuracy, and evidence-based guidelines regarding PSMA PET imaging for patients with suspected or confirmed metastatic or BCR of prostate cancer 

Similar Items